Thomas Hanke
Hoofd Techniek/Wetenschap/O&O bij TeGenero AG
Oorsprong van het eerstegraads netwerk van Thomas Hanke
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Autobahn Labs, Inc.
Autobahn Labs, Inc. Medical/Nursing ServicesHealth Services Autobahn Labs, Inc. is a virtual incubator that partners with research institutions to accelerate the advancement of early-stage drug discovery and development. The company is based in Palo Alto, CA. The organization invests intellectual, financial, and physical capital to efficiently move projects from feasibility to novel drug candidates. Autobahn Labs was created by Samsara Biocapital, Evotec, and KCK Ltd.
7
| Holding Company | Medical/Nursing Services | 7 |
TeGenero AG
TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany.
4
| Private Company | Pharmaceuticals: Major | 4 |
Dark Blue Therapeutics Ltd.
Dark Blue Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Dark Blue Therapeutics Ltd. operates as a biotechnology firm. The company was founded in June 4, 2020 an is headquartered in Oxford, the United Kingdom.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Wuerzburg Schweinfurt University of Applied Sciences
3
| College/University | Other Consumer Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thomas Hanke via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Lonrho Ltd.
Lonrho Ltd. MiscellaneousMiscellaneous Lonrho Ltd. engages in the provision of infrastructure, agribusiness, transportation, hotels and support services. The company was founded on March 31, 1993 and is headquartered in London, the United Kingdom. | Miscellaneous | Director of Finance/CFO | |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Founder | |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Piramed Ltd.
Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Founder Corporate Officer/Principal | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Doctorate Degree | |
JOHNSON SERVICE GROUP PLC | Miscellaneous Commercial Services | Director of Finance/CFO | |
Sportingbet Ltd.
Sportingbet Ltd. Media ConglomeratesConsumer Services Sportingbet Ltd. is engaged in betting and gaming operations over the Internet and telephone in Australia. Its products include sportsbook, casino and games and poker. Sportingbet was founded by Mark Blandford in 1998 and is headquartered in London, the United Kingdom | Media Conglomerates | Director of Finance/CFO | |
University of Freiburg | College/University | Corporate Officer/Principal | |
Rice University | College/University | Undergraduate Degree Doctorate Degree | |
Inform Group Ltd
Inform Group Ltd Commercial Printing/FormsCommercial Services Inform Group Ltd is an e-commerce, digital and litho printing and computer reselling British company. The private company is based in Milton Keynes, UK and has subsidiaries in United Kingdom. | Commercial Printing/Forms | Director of Finance/CFO | |
HBM HEALTHCARE INVESTMENTS AG | Investment Managers | Founder | |
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Undergraduate Degree | |
Max-Planck-Institute for Molecular Genetics | College/University | Doctorate Degree | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
VIVORYON THERAPEUTICS N.V. | Biotechnology | Chairman | |
Nektan UK Ltd.
Nektan UK Ltd. Packaged SoftwareTechnology Services Nektan UK Ltd. designs and develops solutions for mobile phones. The firm enabling businesses to deploy mobile transactional services across multiple devices and in multiple territories. The company was founded by Marcus Wareham, Charles Palmer and Mark Blandford in 2002 and is headquartered in London, the United Kingdom. | Packaged Software | Director/Board Member | |
European Molecular Biology Organization | Corporate Officer/Principal | ||
credentis ag
credentis ag Medical SpecialtiesHealth Technology credentis ag designs, develops, manufactures, and markets dental devices. The firm offers CURODONT. The company was founded by Dominik A. Lysek in January 2010 and is headquartered in Windisch, Switzerland. | Medical Specialties | Chairman | |
Reha-Stim Medtec AG
Reha-Stim Medtec AG Medical SpecialtiesHealth Technology YouRehab AG creates interactive therapy systems for neurological motor disorders. It offers YouGrabber, an all-in-one upper limb rehabilitation product for arms and fingers, which trains patients at peak intensity using rehabilitation gaming to enahcne clinical outcomes; YouKicker, a lower limb rehabilitation product for legs and feet. The company was founded by Oliver Ullmann, Kynan Eng, Edith Chevrier, Lisa Holper, Daniel Kiper, Pawal Pyk and Ewa Siekierka in April 2010 and is headquartered in Schlieren, Switzerland. | Medical Specialties | Director/Board Member | |
Xfund Management Co. LLC
Xfund Management Co. LLC Investment ManagersFinance Xfund Management Co. LLC (Xfund) is a venture capital firm founded in 2011 by Hugo van Vurren. The firm is headquartered in Palo Alto, California. | Investment Managers | Consultant / Advisor | |
NEKTAN PLC | Packaged Software | Chairman | |
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
Wolverhampton Grammar School Ltd. | College/University | Undergraduate Degree | |
MTIP AG
MTIP AG Investment ManagersFinance MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland. | Investment Managers | Private Equity Investor | |
Proxisense Ltd.
Proxisense Ltd. Industrial MachineryProducer Manufacturing Proxisense Ltd. develops proximity sensors and fluid contamination systems for use in extreme environments. The company was founded on September 16, 2014 and is headquartered in Haslemere, the United Kingdom. | Industrial Machinery | Director/Board Member | |
BC Platforms AG
BC Platforms AG Data Processing ServicesTechnology Services BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland. | Data Processing Services | Director/Board Member | |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Founder Consultant / Advisor Private Equity Investor Director of Finance/CFO Private Equity Investor | |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Flame Biosciences LLC
Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder | |
Drug Development Informatics LLC
Drug Development Informatics LLC Packaged SoftwareTechnology Services Drug Development Informatics LLC provides artificial intelligence solutions for the life science industry. | Packaged Software | Consultant / Advisor | |
JIYA ACQUISITION CORP. | Financial Conglomerates | Chairman Director/Board Member Director of Finance/CFO | |
Theia Therapeutics, Inc. | Director/Board Member Director of Finance/CFO | ||
Nalo Therapeutics, Inc.
Nalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nalo Therapeutics, Inc. is a company that focuses on developing therapeutics to address unmet needs in cancer. Nalo Therapeutics is based in Belmont, CA and the CEO of the company is Keith Wilson. The company targets oncogenic driver mutations and/or proteins that are often difficult to drug. The company was founded in 2017 and collaborates with UCSF scientific cofounders. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Isosceles Pharmaceuticals, Inc.
Isosceles Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Isosceles Pharmaceuticals, Inc. is a preclinical stage biotechnology and medical device company that focuses on delivering drug master file backed synthetic cannabinoids for their anti-inflammatory and pain relief properties. The private company is based in Wilmington, NC. The company's proprietary formulations, coupled with unique delivery platforms, provide high bioavailability via parenteral and transdermal routes. Isosceles Pharmaceuticals is a specialty pharmaceutical company with a pipeline of parenteral products designed to target the unmet need of novel non-opioid, non-NSAID analgesics to treat acute pain. William D. Humphries has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Panavance Therapeutics, Inc. | Director/Board Member | ||
AOT AG
AOT AG Medical SpecialtiesHealth Technology AOT AG develops and manufactures robotic surgery equipment. Its technologies include laser photoablation, navigation, planning, and image tools, and real time controlling systems. The company was founded in 2011 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 21 |
Verenigd Koninkrijk | 12 |
Zwitserland | 10 |
Duitsland | 10 |
Sectoraal
Health Technology | 15 |
Commercial Services | 11 |
Finance | 9 |
Consumer Services | 9 |
Technology Services | 5 |
Operationeel
Director/Board Member | 111 |
Corporate Officer/Principal | 51 |
Independent Dir/Board Member | 26 |
Chairman | 22 |
Chief Tech/Sci/R&D Officer | 21 |
Sterkste connecties
Insiders | |
---|---|
Srini Akkaraju Akkaraju | 54 |
Perry Karsen | 38 |
Robert Stein | 34 |
Erich Maximilian Platzer | 31 |
Patrick Baeuerle | 19 |
Claire Brown | 17 |
Richard D. van Doren | 14 |
Stephen Shuttleworth | 13 |
James Henry Wilkinson | 12 |
Peter Laier | 8 |
Nety Krishna | 7 |
Dorothee Nam Poetter | 4 |
Wolfgang Spahn | 3 |
Thomas Huenig | 2 |
Benedikte Hatz | 2 |
- Beurs
- Insiders
- Thomas Hanke
- Bedrijfsconnecties